RPRX - Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields | Benzinga
During times of turbulence and uncertainty in the markets, even when markets are at all-time highs, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting our Analyst Stock Ratings page. Traders can sort through Benzinga's extensive database of analyst ratings, including by analyst accuracy.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector.
Royalty Pharma plc (NASDAQ:RPRX)
- Dividend Yield: 3.06%
- B of A Securities analyst Geoff Meacham maintained a Buy rating and cut the price target from $40 to $38 on April 12. This analyst has an accuracy rate of 64%.
- JP Morgan analyst Chris Schott maintained an Overweight rating and slashed the price target from $45 to $42 on Feb. 20. This analyst has an accuracy ...